Abbasifard Mitra, Moosavi Zahrasadat, Azimi Maryam, Kamiab Zahra, Bazmandegan Gholamreza, Madahian Alimohamad, Raeiszadeh Mahboobeh
Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Internal Medicine Resident, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Pain Manag Nurs. 2025 Feb;26(1):e74-e81. doi: 10.1016/j.pmn.2024.08.001. Epub 2024 Sep 10.
PURPOSE, AND DESIGN: Knee osteoarthritis (OA) is one of the most common and debilitating diseases, especially in the elderly. Hemp seed oil is a plant product that has been used as a food or drug since ancient times because of its anti-inflammatory and analgesic properties.
A double-blind, active, placebo-controlled trial was done to assess the efficacy of hemp seed oil on knee OA. Ninety patients were randomly allocated to three groups; hemp seed oil, diclofenac gel, and placebo via a blocked randomization method, and were asked to apply the topical treatment daily for 2 months. The study participant underwent assessments before, and four and 8 weeks after the intervention. Evaluation included measurements of the heel-to-thigh distance, utilization of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and application of visual analog scale (VAS). Data analysis was performed using SPSS.24 and the significance level was considered as p < .05.
All parameters, except heel-to-thigh distance, improved significantly in the hemp seed oil group compared to placebo group. Improvements in VAS and WOMAC parameters were not different comparing the hemp seed oil and diclofenac gel groups. Heel-to-thigh distance decreased significantly within all groups during the study. There were no significant differences in improvements in heel-to-thigh distance comparing the three groups.
CONCLUSION, AND CLINICAL IMPLICATIONS: Hemp seed oil led to greater improvements in VAS pain score and WOMAC parameters, but not knee flexion range, compared to placebo. There were no differences in measured outcomes comparing hemp seed oil and diclofenac gel.
膝关节骨关节炎(OA)是最常见且使人衰弱的疾病之一,在老年人中尤为如此。大麻籽油是一种植物产品,因其抗炎和止痛特性,自古以来就被用作食品或药物。
进行了一项双盲、活性药物、安慰剂对照试验,以评估大麻籽油对膝关节OA的疗效。90名患者通过区组随机化方法随机分为三组;大麻籽油组、双氯芬酸凝胶组和安慰剂组,并被要求每天进行局部治疗,持续2个月。研究参与者在干预前、干预后4周和8周接受评估。评估包括测量足跟至大腿距离、使用西安大略和麦克马斯特大学骨关节炎指数(WOMAC)以及应用视觉模拟量表(VAS)。使用SPSS.24进行数据分析,显著性水平被认为是p <.05。
与安慰剂组相比,大麻籽油组除足跟至大腿距离外的所有参数均有显著改善。比较大麻籽油组和双氯芬酸凝胶组,VAS和WOMAC参数的改善没有差异。在研究期间,所有组的足跟至大腿距离均显著降低。比较三组,足跟至大腿距离的改善没有显著差异。
与安慰剂相比,大麻籽油在VAS疼痛评分和WOMAC参数方面有更大改善,但在膝关节屈曲范围方面没有改善。比较大麻籽油和双氯芬酸凝胶,测量结果没有差异。